Biolase Expects Big Jump in First-Quarter Sales
- Share via
Biolase Technology Inc., a medical and dental technology products company, said Thursday that it expects first-quarter sales to rise at least 75% from a year ago and doesn’t expect the economic slowdown to hurt overall growth.
The San Clemente company had sales of $1.5 million in last year’s first three months and a net loss of $1 million, or 6 cents a share.
Biolase said in a press release that two new dental lasers, in particular, are being well-received by the market, helping to boost sales this year.
The company’s stock gained 47 cents Thursday to close at $2.03 a share on Nasdaq’s small-cap market.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
